FTO and neoplasm: In acute myeloid leukemia, inhibition of the demethylase FTO decreases the expression of immune checkpoint molecules such as PD-L1 and leukocyte immunoglobulin-like receptor (LILR)B4, enhancing tumor cell sensitivity to T cell-mediated cytotoxicity.